HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.

AbstractAIM:
SonoVue is the first ultrasound contrast agent which allows repeated continuous examination of the liver in real time. The aim of this study was to compare low mechanical index (MI) real time contrast enhanced ultrasound of the liver, using the contrast agent SonoVue, with conventional B-mode sonography for the detection of hepatic metastases.
METHOD:
40 patients with known malignancy and at least one liver lesion on conventional B-mode sonography were included. Conventional B-mode sonography was performed followed by contrast enhanced ultrasound (CEUS) of the liver in the arterial (< 30 sec), portal-venous (40-120 sec) and delayed phase (> 120 sec) after injection of SonoVue. CEUS was performed using contrast specific imaging and low MI (< 0.3). Number, location and size of metastases on baseline and CEUS were compared with CT or MRI (blinded reader).
RESULTS:
37 patients had 128 metastases on CT or MRI. Baseline US showed 74 metastases confirmed by reference examination (69%), while CEUS yielded 109 metastases (sensitivity 90%) (p < 0.001). On CEUS, 35 additional metastases not seen on baseline but confirmed by reference imaging were detected in 14 patients (36%). In 8 patients, CEUS showed 13 metastases not seen on reference imaging.
CONCLUSION:
Detection of hepatic metastases is substantially improved by low MI real time contrast enhanced ultrasound with SonoVue compared to conventional B-mode sonography.
AuthorsA Oldenburg, J Hohmann, E Foert, J Skrok, C W Hoffmann, B Frericks, K J Wolf, T Albrecht
JournalUltraschall in der Medizin (Stuttgart, Germany : 1980) (Ultraschall Med) Vol. 26 Issue 4 Pg. 277-84 (Aug 2005) ISSN: 0172-4614 [Print] Germany
PMID16123921 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Contrast Media
Topics
  • Aged
  • Contrast Media
  • Female
  • Humans
  • Liver Neoplasms (diagnosis, diagnostic imaging, pathology, secondary)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Patient Selection
  • Sensitivity and Specificity
  • Ultrasonography (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: